Every SEC Form 3/4/5 on record for this filer (CIK 1557290) — 6 issuers, 374 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Director | 2019-07-29 → 2026-06-25 | 11 | — |
| PRAX | Praxis Precision Medicines, Inc. | Director | 2026-01-12 → 2026-06-12 | 3 | — |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Director | 2026-01-07 → 2026-05-22 | 3 | — |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | EVP, COO | 2015-07-23 → 2025-07-02 | 107 | −$123M |
| IMGN | ImmunoGen, Inc. | Director · lapsed | 2018-01-24 → 2024-02-12 | 12 | — |
| CERU | Cerulean Pharma Inc. | Director · lapsed | 2016-06-24 → 2017-01-05 | 3 | — |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
4 of 6 issuers are covered and open a security page; the rest are on file here only.